Demographics (2)
- Age_at_diagnosis - Age of patient at diagnosis (phv00220905.v1.p1)
- Gender - Gender of patient (phv00220907.v1.p1)
Disease Events (2)
- LastKnownOutcome - Patient known to be living or deceased at time of study (phv00220908.v1.p1)
- Months_of_survival - Months of survival since diagnosis (phv00220906.v1.p1)
Other (10)
- ANALYTE_TYPE - Molecular analyte (phv00220912.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00220900.v1.p1)
- metastatic_locus_at_diagnosis - Locus of metastatic tumor (phv00220909.v1.p1)
- SAMPID - Sample ID (phv00220902.v1.p1)
- SAMPID - De-identified Sample ID (phv00220910.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00220911.v1.p1)
- SAMPLE_USE - Type of data present. Seq_DNA_SNP_MAF_Ind: Sample(s) were used to generate aggregate mutation annotation file (.maf) with individual SNP genotypes; Seq_DNA_WholeExome: Whole exome sequencing; Seq_DNA_WholeGenome: Whole genome sequencing; Seq_RNA: Whole transcriptome sequencing (phv00220903.v1.p1)
- SUBJID - Unique Participant Identifier (phv00220904.v1.p1)
- SUBJID - Subject ID (phv00220901.v1.p1)
- SUBJID - Subject ID (phv00220899.v1.p1)